# OnCo record label-indication (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/label-indication/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "label-indication" ;
  schema:name "Label, indication and label expansion"@en ;
  schema:alternateName "label expansion"@en, "label expansions"@en, "indication"@en, "approved indication"@en, "new indication"@en, "expanded indication"@en, "expanded label"@en, "expanded approval"@en, "US label"@en, "FDA label"@en, "drug label"@en, "prescribing information"@en, "on-label"@en, "off-label"@en, "off-label use"@en, "sBLA"@en, "sNDA"@en, "supplemental BLA"@en, "supplemental NDA"@en, "supplemental approval"@en, "boxed warning"@en, "black box warning"@en, "label restriction"@en, "boxed warnings"@en, "label restrictions"@en ;
  schema:description "A drug's label is the official document stating exactly which patients (the indication) it is approved for, at what dose, with what warnings. Each new cancer, line of therapy or combination added to it is a label expansion, approved through a supplemental application."@en ;
  schema:url <https://onco.cc/terms/label-indication/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Drug_labelling> ;
  schema:citation <https://en.wikipedia.org/wiki/Drug_labelling> ;
  onco:related <https://onco.cc/terms/bla-nda/>, <https://onco.cc/terms/full-approval/>, <https://onco.cc/terms/accelerated-approval/>, <https://onco.cc/terms/companion-diagnostic-term/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/terms/nccn-compendium/> .